Works matching DE "RISEDRONATE"

Results: 161

Changing trends in bisphosphonate therapy: a twenty-five-year surveillance in a single US integrated healthcare system.

Published in:

Osteoporosis International, 2025, v. 36, n. 4, p. 741, doi. 10.1007/s00198-024-07372-2

By:

Lo, Joan C.;
Chandra, Malini;
Khan, Mehreen M.;
Barzilay, Joshua;
Carbone, Laura D.;
Ott, Susan M.;
Adler, Robert A.;
Schousboe, John T.;
Garcia, Elisha A.;
Low, Deborah;
Hui, Rita L.

Publication type:

Article

Risedronate Effects on the In Vivo Bioactive Glass Behavior: Nuclear Magnetic Resonance and Histopathological Studies.

Published in:

BioMed Research International, 2019, p. 1, doi. 10.1155/2019/2175731

By:

Mosbahi, Siwar;
Oudadesse, Hassane;
Roiland, Claire;
Lefeuvre, Bertrand;
Slimani, Lotfi;
Keskes, Hassib

Publication type:

Article

Bisphosphonates for Secondary Prevention of Osteoporotic Fractures: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Published in:

BioMed Research International, 2019, p. 1, doi. 10.1155/2019/2594149

By:

Shi, Lei;
Min, Nan;
Wang, Fei;
Xue, Qing-Yun

Publication type:

Article

Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole.

Published in:

Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00632

By:

Monda, Vincenzo;
Lupoli, Gelsy A.;
Messina, Giovanni;
Peluso, Rosario;
Panico, Annalisa;
Villano, Ines;
Salerno, Monica;
Sessa, Francesco;
Marciello, Francesca;
Moscatelli, Fiorenzo;
Valenzano, Anna;
Molino, Leonardo;
Lupoli, Roberta;
Fonderico, Francesco;
Tortora, Anna;
Pisano, Agata;
Ruberto, Maria;
Gabriella, Marsala;
Cavaliere, Gina;
Trinchese, Giovanna

Publication type:

Article

Oral risedronate increases Gruen zone bone mineral density after primary total hip arthroplasty: a meta-analysis.

Published in:

Journal of Orthopaedic Surgery & Research, 2018, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13018-018-0794-1

By:

Li, Qifeng;
Xu, Baoshan

Publication type:

Article

Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta-Analysis.

Published in:

Journal of the American Geriatrics Society, 2017, v. 65, n. 3, p. 490, doi. 10.1111/jgs.14668

By:

Nayak, Smita;
Greenspan, Susan L.

Publication type:

Article

The kinetic study of the thermally induced degradation and an evaluation of the drug-excipient interactions performed for a new-generation bisphosphonate—risedronate.

Published in:

Journal of Thermal Analysis & Calorimetry, 2018, v. 134, n. 1, p. 721, doi. 10.1007/s10973-018-7216-9

By:

Vlase, Gabriela;
Albu, Paul;
Doca, Sorin Cristian;
Mateescu, Madalina;
Vlase, Titus

Publication type:

Article

Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019–2023.

Published in:

Osteoporosis International, 2024, v. 35, n. 8, p. 1451, doi. 10.1007/s00198-024-07120-6

By:

Knight, K.J.;
Fordham, R.J.;
Crabtree, N.J.;
Knapp, K.M.

Publication type:

Article

Twelve-month resistance and impact exercise program or risedronate provides a relative benefit to hip bone structure in postmenopausal women: results from a randomized controlled trial.

Published in:

Osteoporosis International, 2024, v. 35, n. 5, p. 877, doi. 10.1007/s00198-023-07008-x

By:

Blay, R.;
Flores, L.E.;
Kupzyk, K.;
Waltman, N.;
Lappe, J.;
Mack, L.;
Bilek, L.

Publication type:

Article

Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.

Published in:

Osteoporosis International, 2023, v. 34, n. 5, p. 977, doi. 10.1007/s00198-022-06627-0

By:

Eisman, John A.;
Cortet, Bernard;
Boolell, Mitra;
Ionescu-Ittu, Raluca;
Vekeman, Francis;
Heroux, Julie;
Thomasius, Friederike

Publication type:

Article

Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study.

Published in:

Osteoporosis International, 2023, v. 34, n. 3, p. 573, doi. 10.1007/s00198-022-06648-9

By:

Tutaworn, Teerapat;
Nieves, Jeri W.;
Wang, Zhaorui;
Levin, Justin E.;
Yoo, Jae E.;
Lane, Joseph M.

Publication type:

Article

Correction to: The clinician's guide to prevention and treatment of osteoporosis.

Published in:

2022

By:

LeBoff, M. S.;
Greenspan, S. L.;
Insogna, K. L.;
Lewiecki, E. M.;
Saag, K. G.;
Singer, A. J.;
Siris, E. S.

Publication type:

Correction Notice

Bone-loading exercises versus risedronate for the prevention of osteoporosis in postmenopausal women with low bone mass: a randomized controlled trial.

Published in:

Osteoporosis International, 2022, v. 33, n. 2, p. 475, doi. 10.1007/s00198-021-06083-2

By:

Waltman, Nancy;
Kupzyk, Kevin A.;
Flores, Laura E.;
Mack, Lynn R.;
Lappe, Joan M.;
Bilek, Laura D.

Publication type:

Article

Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis.

Published in:

Osteoporosis International, 2022, v. 33, n. 1, p. 217, doi. 10.1007/s00198-021-06108-w

By:

Thomasius, Friederike;
Palacios, Santiago;
Alam, Asif;
Boolell, Mitra;
Vekeman, Francis;
Gauthier, Geneviève

Publication type:

Article

Osteoporosis treatment with risedronate: a population pharmacokinetic model for the description of its absorption and low plasma levels.

Published in:

Osteoporosis International, 2021, v. 32, n. 11, p. 2313, doi. 10.1007/s00198-021-05944-0

By:

Cardozo, B.;
Karatza, E.;
Karalis, V.

Publication type:

Article

Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use.

Published in:

Osteoporosis International, 2021, v. 32, n. 7, p. 1413, doi. 10.1007/s00198-020-05794-2

By:

Hayes, K.N.;
He, N.;
Brown, K.A.;
Cheung, A.M.;
Juurlink, D.N.;
Cadarette, S.M.

Publication type:

Article

Upper gastrointestinal safety of oral bisphosphonate in hospitalized patients.

Published in:

Osteoporosis International, 2021, v. 32, n. 1, p. 193, doi. 10.1007/s00198-020-05498-7

By:

Nguyen, P.V.-Q.;
Bouin, M.;
Ste-Marie, L.G.

Publication type:

Article

Efficacy of teriparatide compared with risedronate on FRAX<sup>®</sup>-defined major osteoporotic fractures: results of the VERO clinical trial.

Published in:

Osteoporosis International, 2020, v. 31, n. 10, p. 1935, doi. 10.1007/s00198-020-05463-4

By:

Body, J.-J.;
Marin, F.;
Kendler, D.L.;
Zerbini, C.A.F.;
López-Romero, P.;
Möricke, R.;
Casado, E.;
Fahrleitner-Pammer, A.;
Stepan, J.J.;
Lespessailles, E.;
Minisola, S.;
Geusens, P.

Publication type:

Article

Bisphosphonates and lower mortality risk: when it sounds to be good to be true ...

Published in:

2019

By:

Leslie, W. D.

Publication type:

Editorial

Bisphosphonate drug holidays.

Published in:

Osteoporosis International, 2019, v. 30, n. 12, p. 2525, doi. 10.1007/s00198-019-05107-2

By:

Nayak, S.;
Greenspan, S.L.

Publication type:

Article

Time trends in oral bisphosphonate initiation in Ontario, Canada over 20 years reflect drug policy and healthcare delivery changes.

Published in:

Osteoporosis International, 2019, v. 30, n. 11, p. 2311, doi. 10.1007/s00198-019-05061-z

By:

Hayes, K.N.;
Ban, J.K.;
Athanasiadis, G.;
Burden, A.M.;
Cadarette, S.M.

Publication type:

Article

Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France.

Published in:

Osteoporosis International, 2019, v. 30, n. 3, p. 649, doi. 10.1007/s00198-018-04821-7

By:

Hiligsmann, M.;
Reginster, J.-Y.

Publication type:

Article

Comparison of the efficacy between once-monthly oral ibandronate and risedronate among Korean women with osteoporosis: a nationwide population-based study.

Published in:

Osteoporosis International, 2019, v. 30, n. 3, p. 659, doi. 10.1007/s00198-018-4778-0

By:

Lee, Dong Ryul;
Lee, Jungun

Publication type:

Article

Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison.

Published in:

Osteoporosis International, 2018, v. 29, n. 7, p. 1637, doi. 10.1007/s00198-018-4494-9

By:

Kumagai, K.;
Harigane, K.;
Kusayama, Y.;
Tezuka, T.;
Choe, H.;
Inaba, Y.;
Saito, T.

Publication type:

Article

Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density.

Published in:

Osteoporosis International, 2018, v. 29, n. 6, p. 1407, doi. 10.1007/s00198-018-4460-6

By:

Naylor, K. E.;
Paggiosi, M. A.;
Gossiel, F.;
Walsh, J. S.;
Eastell, R.;
McCloskey, E. V.;
Bradburn, M.;
Peel, N. F. A.

Publication type:

Article

Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.

Published in:

Osteoporosis International, 2017, v. 28, n. 6, p. 1893, doi. 10.1007/s00198-017-3966-7

By:

Imai, T.;
Tanaka, S.;
Kawakami, K.;
Miyazaki, T.;
Hagino, H.;
Shiraki, M.

Publication type:

Article

Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials.

Published in:

Osteoporosis International, 2017, v. 28, n. 4, p. 1279, doi. 10.1007/s00198-016-3848-4

By:

Mawatari, T.;
Muraoka, R.;
Iwamoto, Y.

Publication type:

Article

Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses.

Published in:

Osteoporosis International, 2016, v. 27, n. 11, p. 3289, doi. 10.1007/s00198-016-3654-z

By:

Zhou, J.;
Ma, X.;
Wang, T.;
Zhai, S.

Publication type:

Article

Alendronate- and risedronate-induced acute polyarthritis.

Published in:

Osteoporosis International, 2016, v. 27, n. 11, p. 3383, doi. 10.1007/s00198-016-3695-3

By:

Uğurlar, M.

Publication type:

Article

Clinical and radiographic evaluation of effect of risedronate 5 mg as an adjunct to treatment of chronic periodontitis in postmenopausal women (12-month study).

Published in:

Osteoporosis International, 2016, v. 27, n. 8, p. 2611, doi. 10.1007/s00198-016-3577-8

By:

Bhavsar, N.;
Trivedi, S.;
Dulani, K.;
Brahmbhatt, N.;
Shah, S.;
Chaudhri, D.

Publication type:

Article

Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.

Published in:

Osteoporosis International, 2016, v. 27, n. 6, p. 1989, doi. 10.1007/s00198-015-3476-4

By:

Amiche, M.;
Albaum, J.;
Tadrous, M.;
Pechlivanoglou, P.;
Lévesque, L.;
Adachi, J.;
Cadarette, S.

Publication type:

Article

Treatment of osteoporosis after alendronate or risedronate.

Published in:

Osteoporosis International, 2016, v. 27, n. 1, p. 1, doi. 10.1007/s00198-015-3334-4

By:

Eiken, P.;
Vestergaard, P.

Publication type:

Article

Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study.

Published in:

Osteoporosis International, 2016, v. 27, n. 1, p. 351, doi. 10.1007/s00198-015-3369-6

By:

Ebina, K.;
Noguchi, T.;
Hirao, M.;
Hashimoto, J.;
Kaneshiro, S.;
Yukioka, M.;
Yoshikawa, H.

Publication type:

Article

Bone remodeling markers: so easy to measure, so difficult to interpret.

Published in:

2016

By:

Seeman, E.;
Nguyen, T.

Publication type:

Letter

Bone turnover markers: response to comments by Seeman and Nguyen.

Published in:

2016

By:

Naylor, K.;
Jacques, R.;
Paggiosi, M.;
Gossiel, F.;
Peel, N.;
McCloskey, E.;
Walsh, J.;
Eastell, R.

Publication type:

Letter

Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial.

Published in:

Osteoporosis International, 2015, v. 26, n. 6, p. 1857, doi. 10.1007/s00198-015-3100-7

By:

Greenspan, S.;
Vujevich, K.;
Brufsky, A.;
Lembersky, B.;
Londen, G.;
Jankowitz, R.;
Puhalla, S.;
Rastogi, P.;
Perera, S.

Publication type:

Article

Bone safety with risedronate: histomorphometric studies at different dose levels and exposure.

Published in:

Osteoporosis International, 2015, v. 26, n. 1, p. 327, doi. 10.1007/s00198-014-2850-y

By:

Recker, R.;
Ste-Marie, L.-G.;
Chavassieux, P.;
McClung, M.;
Lundy, M.

Publication type:

Article

Residual effect after oral bisphosphonate treatment and healthy adherer effects-the Swedish adherence register analysis (SARA).

Published in:

Osteoporosis International, 2015, v. 26, n. 1, p. 315, doi. 10.1007/s00198-014-2900-5

By:

Ström, O.;
Landfeldt, E.;
Garellick, G.

Publication type:

Article

Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study.

Published in:

Osteoporosis International, 2014, v. 25, n. 12, p. 2729, doi. 10.1007/s00198-014-2817-z

By:

Paggiosi, M.;
Peel, N.;
McCloskey, E.;
Walsh, J.;
Eastell, R.

Publication type:

Article

Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis.

Published in:

Osteoporosis International, 2013, v. 24, n. 12, p. 2971, doi. 10.1007/s00198-013-2379-5

By:

Farahmand, P.;
Marin, F.;
Hawkins, F.;
Möricke, R.;
Ringe, J. D.;
Glüer, C.-C.;
Papaioannou, N.;
Minisola, S.;
Martínez, G.;
Nolla, J. M.;
Niedhart, C.;
Guañabens, N.;
Nuti, R.;
Martín-Mola, E.;
Thomasius, F.;
Peña, J.;
Graeff, C.;
Kapetanos, G.;
Petto, H.;
Gentzel, A.

Publication type:

Article

Implications of local osteoporosis on the efficacy of anti-resorptive drug treatment: a 3-year follow-up finite element study in risedronate-treated women.

Published in:

Osteoporosis International, 2013, v. 24, n. 12, p. 3043, doi. 10.1007/s00198-013-2424-4

By:

Anitha, D.;
Kim, K. J.;
Lim, S.-K.;
Lee, T.

Publication type:

Article

Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy.

Published in:

Osteoporosis International, 2013, v. 24, n. 8, p. 2345, doi. 10.1007/s00198-013-2332-7

By:

Lindsay, R.;
Watts, N.;
Lange, J.;
Delmas, P.;
Silverman, S.

Publication type:

Article

A meta-analysis characterizing the dose-response relationships for three oral nitrogen-containing bisphosphonates in postmenopausal women.

Published in:

Osteoporosis International, 2013, v. 24, n. 1, p. 253, doi. 10.1007/s00198-012-2179-3

By:

Yates, J.

Publication type:

Article

Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years.

Published in:

Osteoporosis International, 2013, v. 24, n. 1, p. 301, doi. 10.1007/s00198-012-2175-7

By:

Mcclung, M.;
Balske, A.;
Burgio, D.;
Wenderoth, D.;
Recker, R.

Publication type:

Article

Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data.

Published in:

Osteoporosis International, 2013, v. 24, n. 1, p. 293, doi. 10.1007/s00198-012-2056-0

By:

Mcclung, M.;
Zanchetta, J.;
Racewicz, A.;
Roux, C.;
Benhamou, C.-l.;
Man, Z.;
Eusebio, R.;
Beary, J.;
Burgio, D.;
Matzkin, E.;
Boonen, S.;
Delmas, P.

Publication type:

Article

Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.

Published in:

Osteoporosis International, 2012, v. 23, n. 12, p. 2873, doi. 10.1007/s00198-012-1952-7

By:

Pazianas, M.;
Abrahamsen, B.;
Wang, Y.;
Russell, R.

Publication type:

Article

Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women.

Published in:

Osteoporosis International, 2012, v. 23, n. 8, p. 2107, doi. 10.1007/s00198-011-1805-9

By:

Frost, M.;
Siddique, M.;
Blake, G.;
Moore, A.;
Marsden, P.;
Schleyer, P.;
Eastell, R.;
Fogelman, I.

Publication type:

Article

The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures.

Published in:

Osteoporosis International, 2012, v. 23, n. 8, p. 2141, doi. 10.1007/s00198-011-1856-y

By:

Hadji, P.;
Zanchetta, J.;
Russo, L.;
Recknor, C.;
Saag, K.;
McKiernan, F.;
Silverman, S.;
Alam, J.;
Burge, R.;
Krege, J.;
Lakshmanan, M.;
Masica, D.;
Mitlak, B.;
Stock, J.

Publication type:

Article

Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet.

Published in:

Osteoporosis International, 2012, v. 23, n. 1, p. 267, doi. 10.1007/s00198-011-1791-y

By:

McClung, M. R.;
Miller, P. D.;
Brown, J. P.;
Zanchetta, J.;
Bolognese, M. A.;
Benhamou, C. L.;
Balske, A.;
Burgio, D. E.;
Sarley, J.;
McCullough, L. K.;
Recker, R. R.

Publication type:

Article

Journal of Bone and Mineral Metabolism Best Paper Award 2020.

Published in:: Journal of Bone & Mineral Metabolism, 2020, v. 38, n. 6, p. 745, doi. 10.1007/s00774-020-01166-2
Publication type:: Article